Dalma Kinter-Seboek

Allschwil, BL, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Meaningful Within-Patient Change in Subjective Total Sleep Time in Patients with Insomnia Disorder: An Analysis of the Sleep Diary Questionnaire Using Data from Open-Label and Phase III Clinical Trials.

Meaningful Within-Patient Change in Subjective Total Sleep Time in Patients with Insomnia Disorder: An Analysis of the Sleep Diary Questionnaire Using Data from Open-Label and Phase III Clinical Trials.

Journal: Pharmaceutical medicine

Published: December 19, 2023

Number, Duration, and Distribution of Wake Bouts in Patients with Insomnia Disorder: Effect of Daridorexant and Zolpidem.

Number, Duration, and Distribution of Wake Bouts in Patients with Insomnia Disorder: Effect of Daridorexant and Zolpidem.

Journal: CNS drugs

Published: June 21, 2023

Long-Term Safety and Tolerability of Daridorexant in Patients with Insomnia Disorder.

Long-Term Safety and Tolerability of Daridorexant in Patients with Insomnia Disorder.

Journal: CNS drugs

Published: December 01, 2022

Efficacy and Safety of Daridorexant in Older and Younger Adults with Insomnia Disorder: A Secondary Analysis of a Randomised Placebo-Controlled Trial.

Efficacy and Safety of Daridorexant in Older and Younger Adults with Insomnia Disorder: A Secondary Analysis of a Randomised Placebo-Controlled Trial.

Journal: Drugs & aging

Published: September 06, 2022

Preferences of patients for benefits and risks of insomnia medications using data elicited during two phase III clinical trials.

Preferences of patients for benefits and risks of insomnia medications using data elicited during two phase III clinical trials.

Journal: Sleep

Published: January 17, 2022

Development and Validation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ).

Development and Validation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ).

Journal: The patient

Published: October 13, 2020

Daridorexant, a new dual orexin receptor antagonist, in elderly subjects with insomnia disorder.

Daridorexant, a new dual orexin receptor antagonist, in elderly subjects with insomnia disorder.

Journal: Neurology

Published: July 08, 2019

Daridorexant, a New Dual Orexin Receptor Antagonist to Treat Insomnia Disorder.

Daridorexant, a New Dual Orexin Receptor Antagonist to Treat Insomnia Disorder.

Journal: Annals of neurology

Published: July 07, 2019

Showing 1-8 of 8

Last Updated: 09/26/2026